Related Experiment Video
Updated: Oct 21, 2025
Dynamic Monitoring of Seroconversion using a Multianalyte Immunobead Assay for Covid-19
Published on: February 16, 2022
Comparison of two commercial tests (Immy vs. Dynamiker) for cryptococcal capsular antigen
María Clara Noguera1, Patricia Escandón2, Javier Rodríguez3
1Universidad Metropolitana, Grupo Caribe de Enfermedades Infecciosas, Barranquilla, Atlántico, Colombia.
Introduction:
Lateral flow assay is an advanced method useful in the early diagnosis of cryptococcal meningitis. We aimed to compare two commercial tests for cryptococcal capsular antigen in the sera of asymptomatic patients with human immunodeficiency virus in Barranquilla, Colombia.
Methods:
Thawed (n=162) previously collected serums (2016-2019) were processed using IMMY and Dynamiker cryptococcal antigen lateral flow assay.
Results:
Compared to IMMY's results, Dynamiker's sensitivity, specificity, positive predictive value, negative predictive value, and kappa index were 100%, 89.9%, 48.3%, 100.0%, and 0.61, respectively.
Conclusions:
The Dynamiker test had excellent sensitivity, acceptable specificity, and a low detection threshold for cryptococcal antigen in the tested samples.
